China’s Clover says its COVID-19 booster photo candidate lifts antibody against Omicron

BEIJING: China’s Clover Biopharmaceuticals said on Monday (Jun 27) that the booster shot of its COVID-19 vaccine applicant significantly increased antibody response against the Omicron coronavirus variant from levels noticed after two primary shots. A third dose of its vaccine candidate SCB-2019 resulted in a 19-fold increase in neutralising antibodyContinue Reading